![]() |
市場調查報告書
商品編碼
1663688
十二指腸內視鏡的全球市場 - 市場規模(各市場區隔),佔有率,法規,償付,干預,運作台數,預測(~2036年)Duodenoscopes Market Size by Segments, Share, Regulatory, Reimbursement, Interventions, Installed Base and Forecast to 2036 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
十二指腸鏡市場受到多種因素的驅動,其中內視鏡逆行胰膽管造影 (ERCP) 幹預數量的增加、胃腸道疾病、膽石性胰臟炎患者數量的增加以及急性/慢性胰臟炎是主要推動因素。
本報告提供全球十二指腸內視鏡市場相關調查分析,提供各地區市場規模,主要趨勢,創新的產品與技術,競爭情形等資訊。
市場模型的主要組成如下:
十二指腸鏡市場及不斷發展的競爭格局
全球、區域和國家層面的市場洞察
透過獲得真正的整體視角(包括醫療保健系統概述)來了解您的市場。此外,市場進入部分提供有關報銷政策和監管環境的信息,從而可以更深入地了解市場動態。
對象企業
Duodenoscopes Market Size by Segments, Share, Regulatory, Reimbursement, Interventions, Installed Base and Forecast to 2036 is built to visualize quantitative and qualitative market trends within Endoscopy Devices therapeutic area.
A Duodenoscope is a side viewing endoscope primarily designed for Endoscopic Retrograde Cholangiopancreatography (ERCP) for visualization of the interior of the duodenum. All Duodenoscopes are flexible by design, as these have a flexible insertion tube with video recording facility which uses a charge-coupled device to display magnified images onto a video screen.
Duodenoscopes market is driven by a wide variety of factors, however the market is primarily driven by increase in the number of Endoscopic Retrograde Cholangiopancreatography (ERCP) Interventions, GI disorders, increase in patients with gallstone pancreatitis, and acute and chronic pancreatitis.
Each of the covered 39 countries color-coded and fully-sourced market models are equipped with epidemiology based indications with intervention volumes and installed base. The interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are -
Currently marketed Duodenoscopes and evolving competitive landscape -
Global, Regional and Country level market specific insights -
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: Ambu Inc, Boston Scientific Corp, Olympus Corp, KARL STORZ SE & Co KG, Fujifilm Holdings Corp, PENTAX Medical Co, and Others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
The model will enable you to -